Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Haploidentical Stem Cell Transplantation Using PTCY Platform in Paediatric Patients with High-Risk Neuroblastoma
CJ
Cristina Jercan
AB
Ana Maria Bica
IA
Irina Avramescu
Carol Davila University of Medicine and Pharmacy
Ver todo
Puntos clave
Outcomes indicate a significant improvement in pediatric patients after haploidentical stem cell transplantation.
The analysis observed a 30% increase in survival rates compared to previous modalities.
Haploidentical stem cell transplantation was conducted using the PTCY platform to mitigate graft-versus-host disease.
These findings suggest the PTCY method may lead to enhanced treatments for high-risk neuroblastoma cases.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Haploidentical Stem Cell Transplantation Using PTCY Platform in Paediatric Patients with High-Risk Neuroblastoma | Synapse
Cite This Study
Copy
Jercan et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76022c6e9836116a2c95a
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.904